Skip to content

Menu

Network Sub-MenuBrowse by SubjectBrowse by PublisherJoin the NetworkGet StartedSubscribeSupportContact

Search

Close

Enter Search Terms

Grant B. Lukas

ID: 1b83c1ad-2619-30fb-68c4

/

Claimed Record

/

Organization: Rothwell Figg

The Federal Circuit Issues Decision Clarifying the Qualifying Test for Analogous Art

PTAB Law Blog · December 7, 2020

FDA Accepts Review of Samsung Bioepis and Biogen’s Ranibizumab Biosimilar

Biosimilars Law Bulletin · December 2, 2020

US Inventor, Inc. Moves to Prevent Any New AIA Reviews Until <i>NHK-Fintiv</i> is Corrected

PTAB Law Blog · October 12, 2020

Biocon Biologics and Mylan Announce U.S. Launch of Insulin Glargine Product Semglee

Biosimilars Law Bulletin · September 18, 2020

Silicon Valley Challenges the PTAB’s <i>NHK-Fintiv</i> Rule: Can IPRs Be Denied Based on Non-Statutory Factors?

PTAB Law Blog · September 10, 2020

Previous

12 3

Next

Practice Areas

Health Care and Life Sciences

Intellectual Property

Jurisdictions

Washington, D.C.

Publishing Record

Publisher Since 2019

Total Articles 14

Most Recent December 7, 2020

Cite This Author

Grant B. Lukas, Rothwell Figg

LexBlog Author ID:

1b83c1ad-2619-30fb-68c4

www.lexblog.com/author/glukas-2

Contact

FirmRothwell Figg

Emailglukas@rfem.com

BlogsBiosimilars Law Bulletin

Call us at 1-800-913-0988 or email sales@lexblog.com.

Facebook LinkedIn Twitter RSS

About LexBlog
The Field We Built
Library at LexBlog
Our Beliefs
Our Team
Contact LexBlog

Disclaimer
Editorial Policy
Terms of Service

Get Started
Publishing Solutions
Compass

Submit a Request
Support Center
System Status

Copyright © 2026, LexBlog, Inc. All Rights Reserved.

Law blog design & platform by LexBlog